Cerus Corporation(CERS): For the most recent quarter end, Cerus Corporation reported Annual Earnings of $-0.14. Based on the filings, last years Annual Earnings was, $-0.57. For the most recent quarter end, CERS reported a surprise Earnings per Share of 12.5% . The consensus estimate for current quarter is $-0.15 and for the current fiscal year, the estimate is $-0.63. For the Next fiscal year, the estimate is $-0.59 based on the consensus.
Cerus Corporation has received $-0.15 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 2 Financial Advisor in the Stock Trading Firms. Among 2 Analysts, Bottom line EPS Estimate for the current quarter is $-0.15 while the top line estimate is $-0.14 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -3.57%. Cerus Corporation reported better than expected with a surprise EPS of 12.5% or $0.02 during its most recent quarterly earnings. The Actual EPS was $-0.14 compared to the Estimated EPS of $-0.16.
Cerus Corporation Last issued its quarterly earnings results on Nov 3, 2016. The company reported $-0.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.03. Analyst had a consensus of $-0.17. The company had revenue of $10.20 million for the quarter, compared to analysts expectations of $9.82 million. The companys revenue was up 27.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.17 EPS.
Company has reported several Insider transactions to the SEC, on Aug 24, 2016, Kevin Dennis Green (Chief Financial Officer) sold 17,150 shares at 6.80 per share price.On Mar 15, 2016, Chrystal Menard (Chief Legal Officer) sold 8,541 shares at 5.62 per share price.On Sep 2, 2015, Laurence M Corash (Chief Scientific Officer) purchased 19,500 shares at 4.95 per share price.
Cerus Corporation (NASDAQ:CERS) witnessed a decline in the market cap on Wednesday as its shares dropped 2.17% or 0.09 points. After the session commenced at $4.14, the stock reached the higher end at $4.1532 while it hit a low of $4.03. With the volume soaring to 766,542 shares, the last trade was called at $4.05. The company has a 52-week high of $7.64. The company has a market cap of $419 million and there are 103,466,759 shares in outstanding. The 52-week low of the share price is $3.965.
Cerus Corporation is developing medical products based on a platform technology that prevents nucleic acid replication. The companys initial application of this technology is the development of systems to inactivate viruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.